Development of potent thrombin receptor antagonist peptides

Journal of Medicinal Chemistry
M S BernatowiczS M Seiler

Abstract

A peptide-based structure-activity study is reported leading to the discovery of novel potent thrombin receptor antagonists. Systematic substitution of nonproteogenic amino acids for the second and third residues of the human thrombin receptor "tethered ligand" sequence (SFLLR) led to a series of agonists with enhanced potency. The most potent pentapeptide agonist identified was Ser-p-fluoroPhe-p-guanidinoPhe-Leu-Arg-NH2, 9 (EC50 approximately 0.04 microM for stimulation of human platelet aggregation, approximately 10-fold more potent than the natural pentapeptide). Systematic substitution of the NH2-terminal Ser in 9 with neutral hydrophobic NH2-acyl groups led to partial agonists and eventually antagonists with unprecedented potency (greater than 1000-fold increase over the previously reported antagonist 3-mercaptopropionyl-Phe-Cha-Cha-Arg-Lys-Pro-Asn-Asp-Lys-NH2). In the series of NH2-acyl tetrapeptide antagonists, N-transcinnamoyl-p-fluoroPhe-p-guanidinoPhe-Leu-Arg-NH 2, 41 (BMS-197525), was identified as the tightest binding (IC50 approximately 8 nM) and most potent with an IC50 approximately 0.20 microM for inhibition of SFLLRNP-NH2-stimulated platelet aggregation. Systematic single substitutions in 41 indicated that, in ...Continue Reading

References

Oct 30, 1992·Biochemical and Biophysical Research Communications·T SaboE Elhanaty
Aug 19, 1991·FEBS Letters·U B RasmussenE Van Obberghen-Schilling
Jun 15, 1993·The Biochemical Journal·E Van Obberghen-SchillingJ Pouysségur
Aug 1, 1994·Current Opinion in Biotechnology·T W Schwartz
Apr 1, 1993·The Journal of Clinical Investigation·W F BahouM S Goligorsky

❮ Previous
Next ❯

Citations

Sep 25, 2004·Medicinal Research Reviews·Stuti SrivastavaDinesh K Dikshit
Jul 1, 1997·Thrombosis Research·A RayJ B Gupta
Sep 24, 2002·Pharmacology & Therapeutics·Rommel S LanPeter J Henry
Oct 13, 2001·Bioorganic & Medicinal Chemistry Letters·S ChackalamannilG Boykow
Jan 30, 2002·Bioorganic & Medicinal Chemistry Letters·Philippe G NantermetHarold G Selnick
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·W J HoekstraB E Maryanoff
Feb 18, 1999·Bioorganic & Medicinal Chemistry Letters·J T ElliottG D Prestwich
Jun 9, 1999·Bioorganic & Medicinal Chemistry Letters·D F McComseyB E Maryanoff
Aug 18, 1999·Bioorganic & Medicinal Chemistry Letters·H S AhnY Wu
May 3, 2003·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Frederick A Ofosu
Jan 4, 2012·Nature Reviews. Drug Discovery·Rithwik RamachandranMorley D Hollenberg
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·N VergnolleM D Hollenberg
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·I D KuntzP A Kollman
Nov 13, 2004·Oncology·Kunihiro AsanumaAtsumasa Uchida
Mar 17, 1999·The Journal of Clinical Investigation·M L KahnS R Coughlin
Feb 26, 2005·Reproductive Biology and Endocrinology : RB&E·Aonghus J O'LoughlinJohn J Morrison
Oct 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Candice E JungeStephen F Traynelis
Jan 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lidija CovicAthan Kuliopulos
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·S R Coughlin
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·P Andrade-GordonK B White
Jan 31, 2003·Expert Opinion on Investigational Drugs·Claudia K DerianPatricia Andrade-Gordon
Apr 7, 2007·The Journal of Physiology·C Justin LeeStephen F Traynelis
Sep 24, 2011·International Journal of Inflammation·Arthur J Chu
Feb 14, 2012·Pharmacology & Therapeutics·Hannah Lee, Justin R Hamilton
Feb 1, 2011·Pharmacology & Therapeutics·Mark N AdamsJohn D Hooper
Oct 24, 2007·Biochemical Pharmacology·Yingying MaoSatya P Kunapuli
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·S R Coughlin
Jun 12, 2004·Experimental Neurology·Candice E JungeStephen F Traynelis
Nov 13, 2015·Nature Communications·Moritz PfreundschuhDaniel J Müller
Sep 27, 2000·Hematology/oncology Clinics of North America·F A Ofosu, K A Nyarko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.